Skip to main content

Berkshire Hathaway vs Roche: Founders, CEOs and History

Berkshire Hathaway was founded in 1839 by Oliver Chace, Warren Edward Buffett and is led by Greg Abel. Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker.

Company facts

Berkshire Hathaway

Founded
1839
Headquarters
Omaha, Nebraska
Current CEO
Greg Abel
Employees
387,800

Roche

Founded
1896
Headquarters
Basel, Switzerland
Current CEO
Thomas Schinecker
Employees
112,774

Founders

Berkshire Hathaway

  • Oliver Chace

    Berkshire Hathaway is famous not for the men who originally founded it, but for the man who conquered and reinvented it. The original company, the Valley Falls Company, was a textile manufacturer established by Oliver Chace in Rhode Island in 1839.

  • Warren Edward Buffett

    Warren Buffett effectively refounded Berkshire Hathaway beginning in 1965 when his investment partnership gained control of the struggling New England textile company and he became its chairman and CEO.

Berkshire Hathaway founders in full

Roche

  • Fritz Hoffmann-La Roche

    Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.

Roche founders in full

CEOs and their tenures

Berkshire Hathaway

  1. Seabury Stanton1955–1965

    President

    Stanton ran Hathaway Manufacturing from the 1930s and led the 1955 merger with Berkshire Fine Spinning Associates that created Berkshire Hathaway Inc. He closed plants and used liquidation proceeds to buy back stock as New England textiles declined.

    Source
  2. Warren Buffett1965–2025

    Chairman and Chief Executive Officer

    Buffett took control of Berkshire Hathaway in 1965 and turned a shrinking textile maker into a holding company built on insurance float.

    Source
  3. Greg Abel2026–present

    President and Chief Executive Officer

    Abel became President and CEO on January 1, 2026 after the board approved the succession in May 2025.

    Source
Berkshire Hathaway CEO history in full

Roche

  1. Severin Schwan2008–2023

    Chief Executive Officer

    Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.

    Source
  2. Thomas Schinecker2023–present

    Chief Executive Officer

    Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.

    Source
Roche CEO history in full

Timeline: Berkshire Hathaway and Roche side by side

  1. 1839Berkshire Hathaway

    Valley Falls Company Founded

    Oliver Chace founds the Valley Falls Company in Valley Falls, Rhode Island, as a cotton textile manufacturer. Chace had learned the trade working with Samuel Slater and built his first mill in 1806.

  2. 1896Roche

    F. Hoffmann-La Roche Founded in Basel

    Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.

  3. 1898Roche

    Commercial Breakthrough with Sirolin

    Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.

  4. 1934Roche

    First Industrial Synthesis of Vitamin C

    Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.

  5. 1955Berkshire Hathaway

    Berkshire Fine Spinning and Hathaway Manufacturing Merge

    Berkshire Fine Spinning Associates and Hathaway Manufacturing combine and take the Berkshire Hathaway name.

  6. 1962Berkshire Hathaway

    Buffett Partnership Buys Its First Berkshire Shares

    Buffett Partnership Ltd. buys its first Berkshire Hathaway shares in December 1962. Buffett was drawn to the pattern of Berkshire closing plants and using the liquidation proceeds to repurchase its own stock.

  7. 1963Roche

    Launch of Valium (Diazepam)

    Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.

  8. 1964Berkshire Hathaway

    Tender Offer Dispute With Seabury Stanton

    Berkshire president Seabury Stanton asks Buffett at what price Buffett Partnership would sell, agrees to $11.50 a share, then mails a tender offer at $11.375.

  9. 1965Berkshire Hathaway

    Buffett Takes Control and Names Ken Chace President

    Buffett Partnership takes control of Berkshire Hathaway in May 1965 and Stanton leaves. Buffett selects Ken Chace, a long-time employee, as president to run the textile operation, and the cash it generates is pointed at other industries.

  10. 1967Berkshire Hathaway

    Entry Into Insurance With National Indemnity

    Early in 1967 Berkshire pays $8.6 million to buy National Indemnity Company and a small sister insurer from owner Jack Ringwalt.

  11. 1968Roche

    Establishment of Roche Diagnostics

    Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.

  12. 1972Berkshire Hathaway

    See's Candies Bought for $25 Million

    Blue Chip Stamps, controlled by Buffett and Munger and later merged into Berkshire, buys See's Candies for $25 million.

  13. 1985Berkshire Hathaway

    Textile Operations Closed

    Buffett decides in July 1985 to close Berkshire's textile operation and the shutdown is largely complete by year end. He described it as finally throwing in the towel after twenty years of unremitting struggle with the business.

  14. 1996Berkshire Hathaway

    GEICO Becomes Wholly Owned and Class B Shares Created

    Berkshire buys the remaining 49% of GEICO on January 2, 1996, having held 51%, and GEICO becomes a wholly owned subsidiary. Shareholders also approve a recapitalization creating Class B shares with the economic rights of one thirtieth of a Class A share.

  15. 1998Berkshire Hathaway

    General Re and Executive Jet Acquired

    Berkshire acquires reinsurer General Re and fractional-aircraft operator Executive Jet.

  16. 2008Roche

    Severin Schwan becomes CEO

    Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.

  17. 2009Roche

    Full Acquisition of Genentech for $46.8 Billion

    Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.

  18. 2010Berkshire Hathaway

    BNSF Railway Acquired

    Berkshire completes its purchase of Burlington Northern Santa Fe in the first quarter of 2010.

  19. 2016Berkshire Hathaway

    Precision Castparts Acquired

    Berkshire completes the purchase of Precision Castparts, an aerospace and industrial components maker, for $235 a share in cash.

  20. 2018Berkshire Hathaway

    Abel and Jain Named Vice Chairmen

    Berkshire's board expands from twelve to fourteen directors and elects Greg Abel and Ajit Jain.

  21. 2018Roche

    Foundation Medicine & Flatiron Health Acquisitions

    Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.

  22. 2022Berkshire Hathaway

    Alleghany Corporation Acquired

    Berkshire completes the acquisition of insurer Alleghany Corporation on October 19, 2022, paying $848.02 a share in cash for a total equity value of about $11.6 billion and adding the TransRe reinsurance business.

  23. 2023Roche

    Acquired Telavant

    F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.

  24. 2024Berkshire Hathaway

    Market Value Tops $1 Trillion

    Berkshire's market capitalization passes $1 trillion on August 28, 2024, making it the first US company outside the technology sector to reach that level.

  25. 2024Berkshire Hathaway

    Pilot Travel Centers Fully Owned

    Berkshire acquires the remaining 20% of Pilot Travel Centers on January 16, 2024 and takes full ownership. It had bought 38.6% in 2017 and a further 41.4% for about $8.2 billion in January 2023.

  26. 2025Berkshire Hathaway

    Board Approves Abel as CEO From January 2026

    Berkshire announces in May 2025 that Greg Abel will become President and Chief Executive Officer on January 1, 2026, with Warren Buffett remaining Chairman of the Board.

  27. 2025Roche

    Group Sales Reach CHF 61.5 Billion

    Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.

  28. 2026Berkshire Hathaway

    Abel Becomes CEO and Buffett Becomes Chairman Emeritus

    Abel takes over as CEO on January 1, 2026 and Berkshire completes the $9.7 billion purchase of OxyChem from Occidental on January 2. On September 18, 2026 Buffett is named Chairman Emeritus and remains a director, and his son Howard G.

Acquisitions

Berkshire Hathaway

  • OxyChem (Occidental Chemical Corporation)2026$9.7B
  • Alleghany Corporation2022$11.6B
  • Precision Castparts Corp.2016$37.2B
  • Burlington Northern Santa Fe Corporation (BNSF)2010$44B
  • McLane Company2003$1.5B
  • General Re Corporation1998$22B
All Berkshire Hathaway acquisitions

Roche

  • PathAI2026$1.1B
  • 89bio2025$3.5B
  • Telavant2023$7.1B
  • Carmot Therapeutics2023$2.7B
  • Foundation Medicine2018$2.4B
  • ForSight VISION42017Undisclosed
All Roche acquisitions

Questions about Berkshire Hathaway vs Roche

Who is the CEO of Berkshire Hathaway Inc. and F. Hoffmann-La Roche AG?

Berkshire Hathaway Inc. is led by Greg Abel and F. Hoffmann-La Roche AG is led by Thomas Schinecker. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was Berkshire Hathaway Inc. founded vs F. Hoffmann-La Roche AG?

Berkshire Hathaway Inc. was founded in 1839 — 57 years before F. Hoffmann-La Roche AG, which was founded in 1896. Berkshire Hathaway Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger F. Hoffmann-La Roche AG.

How many employees does Berkshire Hathaway Inc. have compared to F. Hoffmann-La Roche AG?

Berkshire Hathaway Inc. employs approximately 387,800 people, while F. Hoffmann-La Roche AG employs approximately 112,774. Berkshire Hathaway Inc. has the larger workforce at 387,800 employees, compared to F. Hoffmann-La Roche AG's 112,774. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are Berkshire Hathaway Inc. and F. Hoffmann-La Roche AG headquartered?

Berkshire Hathaway Inc. is headquartered in United States and F. Hoffmann-La Roche AG is headquartered in Switzerland. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.

Who founded Berkshire Hathaway Inc. and F. Hoffmann-La Roche AG?

Berkshire Hathaway Inc. was founded by Oliver Chace, Warren Edward Buffett. F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche.

Which company has a longer operating history — Berkshire Hathaway Inc. or F. Hoffmann-La Roche AG?

Berkshire Hathaway Inc. has been operating for approximately 187 years, making it the more established of the two companies. F. Hoffmann-La Roche AG has been in operation for around 130 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Berkshire Hathaway vs Roche overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.